Brad Otto

Brad Otto is a Partner at SpringTide Ventures since May 2021, leveraging extensive experience in healthcare technology and venture capital. Otto serves as a Board Observer for OpenLoop, Nest Health, and WearLinq, and as a Board Member for Paloma Health. Additionally, Otto is an Investor in Leash Bio, Aegle Health Partners, Debut, and Sami. Prior experience includes a role as an Associate at UnitedHealth Group Ventures, where involvement focused on early-stage healthcare technology and co-founding Sanvello Health. Otto holds an MBA from Harvard University and has a background from the University of Minnesota - Carlson School of Management.